Introduction
Tetracyclines have been used in the treatment of acne vulgaris for over 15 years and yet their value is still uncertain. The results of double-blind trials are conflicting-for example, Stewart et al. (1963) , Witkowski and Simons (1966) , and Ashurst (1968) confirm their value, while Smith et al. (1962) , Crounse (1965) , and Fry and Ramsay (1966) are of the opinion that tetracyclines have no greater effect than a placebo (Year Book of Dermatology, 1966-7) .
The British Medical Yournal (1966) was critical of the longterm use of tetracyclines and emphasized the expense and the many possible side-effects. It was because of this continued controversy that we undertook yet a further trial with a tetracycline to see if it produced a significant effect in this condition.
The therapeutic results of more than one type of tetracycline, or of other broad-spectrum antibiotics, are not considered here. The questions of total duration of treatment and of possible relapse of acne after stopping tetracycline therapy are also beyond the scope of this paper. 
Investigation
Sixty-one consecutive patients with acne vulgaris attending the skin department of the General Infirmary at Leeds were included initially in the trial. Five failed to attend after the first visit and five others attended twice only. The figures for this trial are based on the 51 patients who attended three times over a period of three months.
There were 25 females aged 12 to 29 years (mean 18 years) and 26 males aged 14 to 23 years (mean 18 years). None of the patients included in the trial had been treated with antibiotics within the previous two months. Forty-four of them had had local treatment in the past, and four had had superficial x-ray therapy over a year previously. The trial was conducted during the winter months (from December 1967 to Ap.ril 1968), when sunshine was minimal.
At the first attendance a clinical assessment was made by completing-table which included descriptions of the lesionsthat is, comedones, papules, pustules, and cysts-and these were then assessed on a scale as being absent, mild, moderate, or severe. The patient was then graded according to the Pillsbury classification 1 to 4 (see Appendix) (Pillsbury et al., 1961) with the addition of half grades.
All patients were instructed not to use any local treatment and to rely entirely on the tablets prescribed. Great emphasis was placed on this, and the patients co-operated very well. They were asked to continue washing as before and to use cosmetics if they wished. Furthermore, they were requested to make no change in their diets. The pharmacist then issued tetracycline hydrochloride 250 mg. tablets, or a placebo identical in appearance, according to a prearranged system of random selection. The dose was one tablet twice a day. The tablets were taken for six weeks, when the patients were seen again by the same doctor. The clinical appearance was again assessed, but on a second form, so that the observer was not aware of the previous marking. The patients' impression of possible progress or deterioration was noted. More tablets were then issued, using the same code, for a further six weeks. After three months' therapy each patient's impressions of the treatment were recorded on a third form, the clinical assessment made, and a new Pillsbury grading given.
On the second and third visits the patients were asked by direct questioning about any side-effects occurring during treatment-for example, pruritus, diarrhoea, dyspepsia, or sore mouth. They were also asked whether they had used any additional treatment themselves.
Colour transparencies of the patients were taken on their first, second, and third visits. Forty-three patients had complete photographic records of each visit, four were photographed before treatment and after six weeks' treatment, and two were photographed before and after three months' treatment. Two patients were not photographed. Where there was no photograph the clinical assessment alone was taken.
Patients with acne on the face were photographed from the front and from each side at each visit, making a set of nine colour transparencies for each patient. The chest and/or back were photographed if indicated. Of the 49 patients photographed, 40 had transparencies of the face, six had transparencies of the face, chest, and/or back, and three had transparencies of the chest and/or back alone.
The photographic technique was standardized (Robinson, 1968) by using an Exa 2B camera with a 100-mm. lens, Kodachrome II film (ASA 25) , an electronic flash, and a green backcloth. For photographing the face a 10-mm. extension tube at 3 ft. (09 m.) and a lens aperture of f.5 6 was used. For chest and/or back views no extension tube was necessary, the distance being 4 ft. (12 m.) and the lens aperture f.5 6.
Methods of Assessment of Therapeutic Response
Two separate methods of assessment were used-namely, clinical and photographic-and the following comparisons were made: (1) the skin lesions before treatment and after six weeks' treatment, and (2) the skin lesions before treatment and after three months' treatment. The key to the therapy was retained by the pharmacist until all patients had been assessed.
Clinical Assessment
On completion of the trial marks were allocated according to the patient's progression or regression along our modification of the Pillsbury scale (see Appendix), one A third independent observer was asked to assess the colour transparencies "blind," using the same method of assessment. His marking was not incorporated into our own final results.
Results

Method 1
The sum of the clinical and photographic assessments (see Tables I and II) helps to minimize any discordant observations -for example, if a patient was thought to have slight clinical improvement (+ 1 on the marking scale) but slight deterioration on photography (-1), the final interpretation was less likely to be reliable than in the case where both clinical and photographic assessments were the same. In this case the patient would register the sum of + 1 and -I= no change.
Whereas, if a patient was given + 1 clinically and + 2 photo- (P<0 001, t=3 9) . At three months the mean improvement of the tetracycline group had increased to 1 8 + 0 3 and that of the placebo group to 0 3 + 0 3-the difference between the groups was again highly significant (P<0 001, t=4 0).
Discussion
It is a common clinical observation that there is a natural variation in the severity of acne, and a double-blind trial is essential. As the results of most previous trials were assessed at the end of two to eight weeks' treatment, it was thought advisable to extend the trial for a minimum of three months and an intermediate assessment was also done at six weeks.
We were advised that it was unnecessary to incorporate a cross-over method into the trial in order to obtain a significant result. By not using this method, any possible residual therapeutic effect in the tetracycline group was also avoided. It was soon seen that the majority of the patients were rated around the Pillsbury grade 2 level, and that changes in the lesions would be small, thus making clinical observation and grading difficult. For this reason, as already described, two separate methods of assessment-namely, clinical and photographic-were used.
Assessment of Colour Transparencies by a Third Observer.-When the third observer's marks of the photographic transparencies were used instead of our own in the calculation of both methods of assessment the results were almost identical with our own.
Local Treatment.-Unlike some observers in the past we did not give patients any local treatment whatsoever, as this would have led to further difficulties in the interpretation of results. For this reason we asked patients on the second and third visits whether they had used any additional treatment. One patient admitted to using his own ultraviolet lamp during the period of observation and was excluded from the trial after his second visit.
Patients' Own Assessment.-The patients' opinion of their progress or deterioration was found to be very close to our own observations and calculations when using the method shown in Tables I and II. Placebo Response.-Many observers have found the placebo response in acne to be around 40 to 50% of patients treated. Our findings in Tables, I and II are in accord with this. When a less sensitive but more realistic index of assessment is used, however, the placebo response is very much less marked, being 7% at six weeks and 33% at three months (see Tables III  and IV) . By chance, the placebo group could have included most of the patients with severe acne-that is, grades 3 and 4 which might have biased the results in favour of the tetracycline group. But a retrospective study of the gradings showed 12 April 1969 Axcne Vulgaris-Lane and Williamson that there were nine patients with grades 3 and 4 in the tetracycline group as compared with four in the placebo group (see Table V ). It is also noteworthy that more patients on placebo (4 out of 27 patients) than on tetracycline (1 out of 24) became worse during the period of observation. Crounse (1965) that a possible cause of the conflicting results of previous double-blind trials may have been variation in the absorption of tetracycline. Crounse (1965) took particular care to instruct his patients to take the tablets before meals so as to give maximum opportunity for absorption. In the present series tablets were prescribed morning and evening with no special instructions relating to mealtimes. We did not specifically check whether the patients had really taken their tablets-failure to do so being, a common cause of " malabsorption " of a drugbut from the results it would appear that sufficient absorption had occurred to give a significant effect. We would not, therefore, attach undue importance to the precise timing of the administration of the tablets.
The British Medical 7ournal (1966) Our results show that tetracyclines are of benefit to about 75 % of patients with acne. The figures after both six weeks' and three months' treatment are significantly in favour of the actively treated group. The group improvement on tetracycline after six weeks' treatment was + 1 with a standard error of ± 0-3-that is, "slightly better "-which may help to explain the variable reports from trials which have been conducted in the past. The group improvement after three months' treatment, however, was 1-8 with a standard error + O-3-that is, "moderately better "-a change easier to interpret both clinically and photographically. Although the numbers of the tetracycline group are not large enough to show a statistically significant improvement at three months' treatment as compared with six weeks' treatment, the general trend to further improvement at three months should be noted, The response of each of the Pillsbury grades of acne to tetracycline hydrochloride therapy is shown in Table V . These figures are shown for interest, as the numbers are not large enough to show statistical significance.
Expense.-The cost of treating a patient with acne from a hospital dispensary is about four shillings a week when using tetracycline hydrochloride in a dosage of two tablets a day.
Toxic Effects.-The toxic effects of the tetracyclines are well summarized by Clendenning (1965) . None of our patients had such well-recognized complications as nausea, pruritus ani, etc., but we did have one patient complain that she had great discomfort with her contact lenses after being on the tablets for 10 weeks. Previously she had had no trouble with the lenses, which she had worn for two years. This discomfort was relieved as soon as she stopped taking the tablets, but returned within one week of restarting them. So far as we know this side-effect has not been mentioned before. We would suggest that the young, fit age group with acne is less liable to sideeffects than the middle-aged and elderly group with rosacea.
We agree that tetracyclines should not be given during pregnancy, and patients should be warned to stop the tablets should they miss a period. In our opinion the side-effects of tetracycline, as used in acne in healthy young adults, are grossly overexaggerated. 
